Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Inventory (2022 - 2024)

Historic Inventory for PAVmed (PAVM) over the last 3 years, with Q2 2024 value amounting to $687000.0.

  • PAVmed's Inventory changed N/A to $687000.0 in Q2 2024 from the same period last year, while for Jun 2024 it was $687000.0, marking a year-over-year change of. This contributed to the annual value of $278000.0 for FY2023, which is 15045.05% up from last year.
  • PAVmed's Inventory amounted to $687000.0 in Q2 2024.
  • PAVmed's Inventory's 5-year high stood at $687000.0 during Q2 2024, with a 5-year trough of $111000.0 in Q4 2022.
  • In the last 3 years, PAVmed's Inventory had a median value of $344000.0 in 2023 and averaged $371500.0.
  • The largest annual percentage gain for PAVmed's Inventory in the last 5 years was 15045.05% (2023), contrasted with its biggest fall of 15045.05% (2023).
  • PAVmed's Inventory (Quarter) stood at $111000.0 in 2022, then soared by 150.45% to $278000.0 in 2023, then skyrocketed by 147.12% to $687000.0 in 2024.
  • Its last three reported values are $687000.0 in Q2 2024, $410000.0 for Q1 2024, and $278000.0 during Q4 2023.